AAAAAA
Results: 1201-1225/15678
Authors:
Yuen, MF
Lau, CS
Lau, YL
Wong, WM
Cheng, CC
Lai, CL
Citation: Mf. Yuen et al., Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection, HEPATOLOGY, 29(4), 1999, pp. 1248-1251
Authors:
Friedt, M
Gerner, P
Lausch, E
Trubel, H
Zabel, B
Wirth, S
Citation: M. Friedt et al., Mutations in the basic core promotor and the precore region of hepatitis Bvirus and their selection in children with fulminant and chronic hepatitisB, HEPATOLOGY, 29(4), 1999, pp. 1252-1258
Authors:
Collier, JD
Zanke, B
Moore, M
Kessler, G
Krajden, M
Shepherd, F
Heathcote, J
Citation: Jd. Collier et al., No association between hepatitis C and B-cell lymphoma, HEPATOLOGY, 29(4), 1999, pp. 1259-1261
Authors:
Polyak, SJ
Paschal, DM
McArdle, S
Gale, MJ
Moradpour, D
Gretch, DR
Citation: Sj. Polyak et al., Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication, HEPATOLOGY, 29(4), 1999, pp. 1262-1271
Authors:
Asti, M
Martinetti, M
Zavaglia, C
Cuccia, MC
Gusberti, L
Tinelli, C
Cividini, A
Bruno, S
Salvaneschi, L
Ideo, G
Mondelli, MU
Silini, EM
Citation: M. Asti et al., Human leukocyte antigen class II and III alleles and severity of hepatitisC virus-related chronic liver disease, HEPATOLOGY, 29(4), 1999, pp. 1272-1279
Authors:
Zeuzem, S
Hopf, U
Carreno, V
Diago, M
Shiffman, M
Grune, S
Dudley, FJ
Rakhit, A
Rittweger, K
Yap, SH
Koff, RS
Thomas, HC
Citation: S. Zeuzem et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C, HEPATOLOGY, 29(4), 1999, pp. 1280-1287
Authors:
Beld, M
Penning, M
van Putten, M
Lukashov, V
van den Hoek, A
McMorrow, M
Goudsmit, J
Citation: M. Beld et al., Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: Impact of epitope variation and relationship to detection of HCV RNA in blood, HEPATOLOGY, 29(4), 1999, pp. 1288-1298
Authors:
Adler, R
Safadi, R
Caraco, Y
Rowe, M
Etzioni, A
Ashur, Y
Shouval, D
Citation: R. Adler et al., Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation, HEPATOLOGY, 29(4), 1999, pp. 1299-1305
Authors:
Colin, JF
Cazals-Hatem, D
Loriot, MA
Martinot-Peignoux, M
Pham, BN
Auperin, A
Degott, C
Benhamou, JP
Erlinger, S
Valla, D
Marcellin, P
Citation: Jf. Colin et al., Influence of human immunodeficiency virus infection on chronic hepatitis Bin homosexual men, HEPATOLOGY, 29(4), 1999, pp. 1306-1310
Authors:
Hu, KQ
Tong, MJ
Citation: Kq. Hu et Mj. Tong, The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States, HEPATOLOGY, 29(4), 1999, pp. 1311-1316
Authors:
Barraud, L
Guerret, S
Chevallier, M
Borel, C
Jamard, C
Trepo, C
Wild, CP
Cova, L
Citation: L. Barraud et al., Enhanced duck hepatitis B virus gene expression following aflatoxin B-1 exposure, HEPATOLOGY, 29(4), 1999, pp. 1317-1323
Authors:
Adams, PC
Citation: Pc. Adams, Population screening for hemochromatosis, HEPATOLOGY, 29(4), 1999, pp. 1324-1327
Authors:
McCullough, AJ
Falck-Ytter, Y
Citation: Aj. Mccullough et Y. Falck-ytter, Body composition and hepatic steatosis as precursors for fibrotic liver disease, HEPATOLOGY, 29(4), 1999, pp. 1328-1330
Authors:
Koziel, MJ
Citation: Mj. Koziel, What once was lost, now is found: Restoration of hepatitis B-specific immunity after treatment of chronic hepatitis B - Comments, HEPATOLOGY, 29(4), 1999, pp. 1331-1333
Authors:
Thomas, HC
Torok, ME
Foster, GR
Citation: Hc. Thomas et al., Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy - Comments, HEPATOLOGY, 29(4), 1999, pp. 1333-1334
Authors:
Hofmann, AF
Citation: Af. Hofmann, Regulation of ileal bile acid transport: Desirability of measuring transport function as well as transporter activity, HEPATOLOGY, 29(4), 1999, pp. 1335-1336
Authors:
Shneider, BL
Citation: Bl. Shneider, Regulation of ileal bile acid transport: Desirability of measuring transport function as well as transporter activity - Reply, HEPATOLOGY, 29(4), 1999, pp. 1336-1337
Authors:
Pastor-Anglada, M
Casado, FJ
Felipe, A
Mata, JF
Valdes, R
de Santo, B
Citation: M. Pastor-anglada et al., Sodium purine nucleoside transporter - Reply, HEPATOLOGY, 29(4), 1999, pp. 1337-1337
Authors:
Arias, IM
Citation: Im. Arias, Sodium purine nucleoside transporter, HEPATOLOGY, 29(4), 1999, pp. 1337-1337
Authors:
Amaral, OB
Quevedo, J
Walz, R
Kapczinski, F
Citation: Ob. Amaral et al., Flumazenil and hepatic encephalopathy, HEPATOLOGY, 29(4), 1999, pp. 1338-1339
Authors:
Hezode, C
Cazeneuve, C
Coue, O
Roudot-Thoraval, F
Pawlotsky, JM
Zafrani, ES
Amselem, S
Dhumeaux, D
Citation: C. Hezode et al., Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis, HEPATOLOGY, 29(4), 1999, pp. 1338-1338
Authors:
Barbaro, G
Barbarini, G
Citation: G. Barbaro et G. Barbarini, Flumazenil and hepatic encephalopathy - Reply, HEPATOLOGY, 29(4), 1999, pp. 1339-1339
Authors:
McKillop
Citation: Mckillop, Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma (vol 29, pg 412, 1999), HEPATOLOGY, 29(4), 1999, pp. 1340-1340
Authors:
Clement, B
Musso, O
Lietard, J
Theret, N
Citation: B. Clement et al., Homeostatic control of angiogenesis: A newly identified function of the liver?, HEPATOLOGY, 29(3), 1999, pp. 621-623
Authors:
Chen, QY
Rowley, MJ
Mackay, IR
Citation: Qy. Chen et al., Anti-idiotypic antibodies to anti-PDC-E3 in primary biliary cirrhosis and normal subjects, HEPATOLOGY, 29(3), 1999, pp. 624-631